MK-0859

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0859, covering 2015-02-25 to 2015-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) [Phase 1]

See pricing